342 related articles for article (PubMed ID: 26614029)
21. HtrA1 in human urothelial bladder cancer: a secreted protein and a potential novel biomarker.
Lorenzi T; Lorenzi M; Altobelli E; Marzioni D; Mensà E; Quaranta A; Paolinelli F; Morroni M; Mazzucchelli R; De Luca A; Procopio AD; Baldi A; Muzzonigro G; Montironi R; Castellucci M
Int J Cancer; 2013 Dec; 133(11):2650-61. PubMed ID: 23712470
[TBL] [Abstract][Full Text] [Related]
22. Use of monoclonal antibodies for the diagnosis and treatment of bladder cancer.
Syrigos KN; Deonarian DP; Epenetos AA
Hybridoma; 1999 Jun; 18(3):219-24. PubMed ID: 10475235
[TBL] [Abstract][Full Text] [Related]
23. Genetic and epigenetic biomarkers for early detection, therapeutic effectiveness and relapse monitoring in bladder cancer.
Dumache R; David D; Kaycsa A; Minciu R; Negru S; Puiu M
Rev Med Chir Soc Med Nat Iasi; 2011; 115(1):163-7. PubMed ID: 21682190
[TBL] [Abstract][Full Text] [Related]
24. Small cell carcinoma of the bladder: the characteristics of molecular alterations, treatment, and follow-up.
Wang Y; Li Q; Wang J; Tong M; Xing H; Xue Y; Pan H; Huang C; Li D
Med Oncol; 2019 Oct; 36(12):98. PubMed ID: 31664527
[TBL] [Abstract][Full Text] [Related]
25. miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer.
Puerta-Gil P; García-Baquero R; Jia AY; Ocaña S; Alvarez-Múgica M; Alvarez-Ossorio JL; Cordon-Cardo C; Cava F; Sánchez-Carbayo M
Am J Pathol; 2012 May; 180(5):1808-15. PubMed ID: 22426337
[TBL] [Abstract][Full Text] [Related]
26. Molecular biomarkers for predicting outcomes in urothelial carcinoma of the bladder.
Sapre N; Herle P; Anderson PD; Corcoran NM; Hovens CM
Pathology; 2014 Jun; 46(4):274-82. PubMed ID: 24798156
[TBL] [Abstract][Full Text] [Related]
27. Gene-based urinary biomarkers for bladder cancer: an unfulfilled promise?
Sapre N; Anderson PD; Costello AJ; Hovens CM; Corcoran NM
Urol Oncol; 2014 Jan; 32(1):48.e9-17. PubMed ID: 24140246
[TBL] [Abstract][Full Text] [Related]
28. Molecular pathogenesis and diagnostics of bladder cancer.
Mitra AP; Cote RJ
Annu Rev Pathol; 2009; 4():251-85. PubMed ID: 18840072
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic biomarkers in urothelial bladder cancer.
Kim WJ; Kim YJ
Expert Rev Mol Diagn; 2009 Apr; 9(3):259-69. PubMed ID: 19379084
[TBL] [Abstract][Full Text] [Related]
30. What are the expected developments in the medical treatment of bladder cancer.
Bellmunt J
Eur J Cancer; 2011 Sep; 47 Suppl 3():S294-7. PubMed ID: 21943989
[No Abstract] [Full Text] [Related]
31. Biomarkers for bladder cancer aggressiveness.
Frantzi M; Makridakis M; Vlahou A
Curr Opin Urol; 2012 Sep; 22(5):390-6. PubMed ID: 22825458
[TBL] [Abstract][Full Text] [Related]
32. Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet?
Netto GJ
Nat Rev Urol; 2011 Dec; 9(1):41-51. PubMed ID: 22158597
[TBL] [Abstract][Full Text] [Related]
33. Advances in Biomarkers for Detection, Surveillance, and Prognosis of Bladder Cancer.
Henning GM; Barashi NS; Smith ZL
Clin Genitourin Cancer; 2021 Jun; 19(3):194-198. PubMed ID: 33781702
[TBL] [Abstract][Full Text] [Related]
34. Toward critical evaluation of the role(s) of molecular biomarkers in the management of bladder cancer.
Nielsen ME; Gonzalgo ML; Schoenberg MP; Getzenberg RH
World J Urol; 2006 Nov; 24(5):499-508. PubMed ID: 17102951
[TBL] [Abstract][Full Text] [Related]
35. Pathological possibilities and pitfalls in detecting aggressive bladder cancer.
Mitra AP; Jordà M; Cote RJ
Curr Opin Urol; 2012 Sep; 22(5):397-404. PubMed ID: 22825461
[TBL] [Abstract][Full Text] [Related]
36. Biomarkers for precision medicine in bladder cancer.
Kojima T; Kawai K; Miyazaki J; Nishiyama H
Int J Clin Oncol; 2017 Apr; 22(2):207-213. PubMed ID: 27896485
[TBL] [Abstract][Full Text] [Related]
37. Molecular genetics and genomics progress in urothelial bladder cancer.
Netto GJ
Semin Diagn Pathol; 2013 Nov; 30(4):313-20. PubMed ID: 24342287
[TBL] [Abstract][Full Text] [Related]
38. Urothelial neoplasms of the urinary bladder occurring in young adult and pediatric patients: a comprehensive review of literature with implications for patient management.
Paner GP; Zehnder P; Amin AM; Husain AN; Desai MM
Adv Anat Pathol; 2011 Jan; 18(1):79-89. PubMed ID: 21169741
[TBL] [Abstract][Full Text] [Related]
39. Molecular pathology and biomarkers of bladder cancer.
Czerniak B
Cancer Biomark; 2010; 9(1-6):159-76. PubMed ID: 22112475
[TBL] [Abstract][Full Text] [Related]
40. Urine biomarkers of schistosomiais and its associated bladder cancer.
Eissa S; Matboli M; Shawky S; Essawy NO
Expert Rev Anti Infect Ther; 2015 Aug; 13(8):985-93. PubMed ID: 26105083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
